Bristol Myers Squibb BMY
NYSE BMY
$62.93 -0.50 (-0.79%)
At close: Nov 16, 2026 · 4:00 PM EST

Bristol Myers Squibb (BMY) Income from Discontinued Operations (2009)

Updated

Bristol Myers Squibb's Income from Discontinued Operations was $7.22 billion in Q4 2009.

Analysis

Bristol Myers Squibb (BMY) Income from Discontinued Operations (2009) Analysis & Trends

For FY2009, Income from Discontinued Operations at Bristol Myers Squibb came in at $7.44 billion.

  • Per Business Quant data, BMY's Income from Discontinued Operations in the three quarters before Q4 2009 was $91 million (Q3 2009), $129 million (Q2 2009) and -$11 million (Q1 2009).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Discontinued) (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn -
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn -
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn -
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn -
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn -
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn -
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn -
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn -
10 Bristol Myers Squibb 128.63 Bn 83.82 Bn 8.92 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2009 7.22 Bn
Sep 30, 2009 91.00 Mn
Jun 30, 2009 129.00 Mn
Mar 31, 2009 -11.00 Mn
API Access

Bristol Myers Squibb Income from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-from-discontinued-operations&ticker=BMY&period=max&api_key=YOUR_API_KEY